Pacific Edge Limited

PINK:PFGTF USA Diagnostics & Research
Market Cap
$80.76 Million
Market Cap Rank
#19746 Global
#7233 in USA
Share Price
$0.08
Change (1 day)
+0.00%
52-Week Range
$0.08 - $0.11
All Time High
$1.20
About

Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic produc… Read more

Pacific Edge Limited (PFGTF) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.712x

Based on the latest financial reports, Pacific Edge Limited (PFGTF) has a cash flow conversion efficiency ratio of -0.712x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-19.00 Million) by net assets ($26.70 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Pacific Edge Limited - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Pacific Edge Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Pacific Edge Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pacific Edge Limited ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Pacific Edge Limited (2013–2025)

The table below shows the annual cash flow conversion efficiency of Pacific Edge Limited from 2013 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 $26.09 Million $-24.74 Million -0.948x -101.19%
2024-03-31 $54.62 Million $-25.75 Million -0.471x -62.97%
2023-03-31 $88.41 Million $-25.57 Million -0.289x -92.16%
2022-03-31 $116.60 Million $-17.55 Million -0.151x +72.15%
2021-03-31 $25.11 Million $-13.57 Million -0.540x +49.05%
2020-03-31 $14.50 Million $-15.38 Million -1.061x +15.72%
2019-03-31 $13.91 Million $-17.51 Million -1.259x -15.71%
2018-03-31 $16.64 Million $-18.10 Million -1.088x -27.02%
2017-03-31 $20.83 Million $-17.84 Million -0.856x -50.57%
2016-03-31 $29.81 Million $-16.95 Million -0.569x +51.46%
2015-03-31 $10.70 Million $-12.54 Million -1.172x -167.91%
2014-03-31 $21.78 Million $-9.52 Million -0.437x +27.37%
2013-03-31 $11.15 Million $-6.71 Million -0.602x --